Roy Brown

17 Flips | 2 Magazines | 232 Likes | 52 Following | 10 Followers | @Robbinsville | Keep up with Roy Brown on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Roy Brown”

Alcohol intake is linked to cancer, something most Americans are unaware of, warns ASCO

Wait, wait — can you say that on air? There’s a debate on cursing at NPR.

To bleep or not to bleep? Or more specifically, to bleep only part of a potentially offensive word in a broadcast-news story or to let it all hang out?<p>Those questions seem to have sparked a lively — and not suitable for audiences of all ages — debate within NPR over the past two weeks. Journalists …

The coming Alzheimer’s crisis in America

Current quibbling over what Jeb Bush meant when he said it’s time to phase out and replace Medicare — as opposed to “attacking the seniors,” as one woman at a recent event bellowed out — will soon seem quaint against the realities of our future.<p>Never mind projections that the program will be able …

J.R. Smith Says Cleveland's Lack of Partying Has Helped His Game

For the last decade or so, basketball experts have tried in vain to figure out the human Russian roulette routine that is J.R. Smith.<p>His buckets come and go in spurts, with Kanye shrugs for the bad days and rapture for the good ones. Many have guessed at but could never really pinpoint anything …

The Doctor Who Coaches Athletes on Sleep

As the NBA and NHL playoffs start, a Harvard sleep specialist advises rest, not more practice, for championship teams.<p>On June 14, 2011, Dr. Charles Czeisler stood by the side of a small stage, listening as a colleague introduced him to a crowd of fellow researchers. Just as he prepared to ascend …

Costly Hepatitis C Pill Shreds Drug Industry Sales Record

The launch of Sovaldi, the $1,000-a-day pill for hepatitis C, is shaping up as the most successful ever.<p>The Food and Drug Administration approved the pill in December. And then Gilead Sciences was off to the races. The company said it sold $2.27 billion worth of Sovaldi in the quarter that ended …